|
|
 |
|
Viewing report
|
|
|
|
Opportunities in Menopausal Treatments: Will New Therapies Overtake Hormone Replacement?
Decision Resources, Inc., June 2009, Pages: 37
For decades, the efficacy of hormone replacement therapy (HRT) for some of menopause’s most troublesome symptoms eliminated any incentive to develop new approaches to treatment. However, data questioning the safety of estrogen-containing therapies have galvanized researchers and drug developers to begin investigating new mechanisms to treat menopausal symptoms that can capitalize on the newly realized need for safer treatment options, although these agents will still be challenged by the efficacy of HRTs.
Questions Answered in This Report
- Menopause is a natural process of aging that is accompanied by substantial hormonal changes. What are the symptoms of menopause? What are the causes of these symptoms? What are the current treatment options? What are the benefits and drawbacks of these treatments?
- Data from the Women’s Health Initiative suggest that estrogen therapy is not suitable for all women. What are the risks associated with hormone therapy? Do emerging agents offer safer or more efficacious treatment approaches?
- With the final wave of baby boomers reaching menopausal age, the menopause treatment patient population is on the rise. What were the sales of menopausal symptom treatments in 2008? How well will emerging agents address the remaining needs in this market? How will emerging agents fit into the treatment algorithm in the future?
Scope
- Overview of menopause: Physiology and symptoms.
- Current treatments: Hormone replacement therapy, selective estrogen receptor modulators, SSRIs/SNRIs, gabapentin.
- Emerging treatments: Wyeth’s Pristiq, Wyeth’s bazedoxifene/conjugated estrogens, Depomed’s controlled-release gabapentin, Schering-Plough’s esmirtazapine.
- Outlook: 2008 market, challenges and opportunities, the potential of emerging agents, the future of HRT.
- Women’s Health Series: This report is part of Spectrum’s Women’s Health Series, which focuses on areas of unmet need and the best marketing strategies to ensure adoption of a new agent into the market for women’s reproductive health—a sector that exceeded $23 billion in 2007.
Customers who bought this item also bought
Hormone Replacement Therapy (HRT) - Global Strategic Business Report
Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018
Pipeline and Commercial Insight: Hormonal Replacement Therapy for Menopausal Symptoms - Safety fears continue to haunt the market
Commercial And Pipeline Insight: HRT For Menopausal Symptoms – A New Class Restores An Old Market
Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
R&D Trends: Women's Health - Investment needed to address lack of innovation
R&D Update: What's on the Horizon for the Panic Disorder Market?
Are There Changes Ahead for the Generalized Anxiety Disorder Market?
The Women’s Health Market Outlook to 2016
Can a New Antidepressant Establish Itself in a Highly Competitive Market?
|
|
|
|
